Drug Profile
Siratiazem
Alternative Names: LRA 113Latest Information Update: 24 Jan 1995
Price :
$50
*
At a glance
- Originator Istituto Lusofarmaco
- Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders
Most Recent Events
- 24 Jan 1995 Discontinued-Preclinical for Arrhythmias in Italy (Unknown route)
- 24 Jan 1995 Discontinued-Preclinical for Ischaemic heart disorders in Italy (Unknown route)